Stay updated on mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Sign up to get notified when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page

  1. Check
    7 days ago
    Change Detected
    Summary
    The KEYNOTE-942 study record is displayed, with details on its mRNA-4157 and pembrolizumab treatments, eligibility criteria, study locations, outcomes, and publications, instead of a 403 error page.
    Difference
    55%
    Check dated 2026-11-08T06:22:33.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T04:19:08.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T06:26:21.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The footer now identifies the site as revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T05:09:56.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The site revision identifier in the footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T06:50:42.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page's study record dates were updated to reflect new postings and milestones: new dates (2026-09-08, 2026-09-02, 2026-08, 2032-11-21) were added and older dates (2025-12-03, 2032-11-30, 2025-12-02, 2025-11) were removed.
    Difference
    0.3%
    Check dated 2026-09-13T01:29:24.000Z thumbnail image

Stay in the know with updates to mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the mRNA-4157 Vaccine and Pembrolizumab in Melanoma Clinical Trial. page.